EFFECTIVENESS OF SERUM PSA, URINE PCA3 AND URINE TMPRSS2: ERG FUSION AS A NOVEL URINARY BIOMARKER PANEL IN CLINICAL PRACTICE

被引：0
|
作者：
Wei, John
Siddiqui, Javed
Siddiqui, Rabia
Chinnaiyan, Arul M.
Kunju, Lakshmi P.
Mehra, Rohit
Snyder, Debbie
Tomlins, Scott A.
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 04期
关键词：
D O I：
10.1016/j.juro.2015.02.2553
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD44-07
引用
收藏
页码：E899 / E900
页数：2
相关论文
共 50 条
  • [41] Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)
    Lisa F. Newcomb
    Yingye Zheng
    Anna V. Faino
    Daniella Bianchi-Frias
    Matthew R. Cooperberg
    Marshall D. Brown
    James D. Brooks
    Atreya Dash
    Michael D. Fabrizio
    Martin E. Gleave
    Michael Liss
    Todd M. Morgan
    Ian M. Thompson
    Andrew A. Wagner
    Peter R. Carroll
    Peter S. Nelson
    Daniel W. Lin
    Prostate Cancer and Prostatic Diseases, 2019, 22 : 438 - 445
  • [42] Detection of TMPRSS2-ERG fusion transcripts and PCA3 in urinary sediments may improve diagnosis of prostate cancer
    Hessels, Daphne
    Smit, Frank P.
    Verhaegh, Gerald W.
    Witjes, J. Alfred
    Comel, Erik B.
    Schalken, Jack A.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 685 - 685
  • [43] Diagnostic value of PCA3, TMPRSS2:ERG and prostatic specific antigen derivatives in the detection of prostate cancer
    Musaelyan, A. A.
    Nazarov, V. D.
    Lapin, S., V
    Boriskin, A. G.
    Reva, S. A.
    Lebedev, D. G.
    Yakovlev, V. D.
    Viktorov, D. A.
    Toropovskiy, A. N.
    Emanuel, V. L.
    Al-Shukri, S. Kh
    Petrov, S. B.
    ONKOUROLOGIYA, 2020, 16 (02): : 65 - 73
  • [44] Detection of TMPRSS2-ERG fusion transcripts and PCA3 in urinary sediments may improve diagnosis of prostate cancer
    Hessels, D.
    Smit, F. P.
    Verhaegh, G. W.
    Witjes, J. A.
    Schalken, J. A.
    Cornel, E. B.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 140 - 140
  • [45] Detection of TMPRSS2-ERG fusion transcripts and PCA3 in urinary sediments may improve diagnosis of prostate cancer
    Hessels, D.
    Smit, F. P.
    Verhaegh, G. W.
    Witjes, J. A.
    Cornel, E. B.
    Schalken, J. A.
    BJU INTERNATIONAL, 2007, 100 : 27 - 27
  • [46] URINARY PCA3 AND TMPRSS2: ERG HELP PREDICT BIOPSY OUTCOME PRIOR TO INITIAL PROSTATE BIOPSY USING A RISK GROUP ANALYSIS
    Jones, LeRoy
    Day, John
    Meyer, Sarah
    Hodge, Petrea
    Aussie, Jacqueline
    Groskopf, Jack
    Saltzstein, Daniel
    JOURNAL OF UROLOGY, 2013, 189 (04): : E872 - E872
  • [47] Utility of PCA3 and TMPRSS2: ERG urinary biomarkers to predict pathologic outcomes in African American men undergoing radical prostatectomy.
    Feibus, Allison H.
    Sartor, Oliver
    Ledet, Elisa M.
    Shaw, Eric
    Moparty, Krishnarao
    Thomas, Raju
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [48] Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study
    Lin, Daniel W.
    Newcomb, Lisa F.
    Brown, Elissa C.
    Brooks, James D.
    Carroll, Peter R.
    Feng, Ziding
    Gleave, Martin E.
    Lance, Raymond S.
    Sanda, Martin G.
    Thompson, Ian M.
    Wei, John T.
    Nelson, Peter S.
    CLINICAL CANCER RESEARCH, 2013, 19 (09) : 2442 - 2450
  • [49] TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis
    Rostad, Kari
    Hellwinkel, Olaf J. C.
    Haukaas, Svein A.
    Halvorsen, Ole J.
    Oyan, Anne M.
    Haese, Alexander
    Budaus, Lars
    Albrecht, Heiko
    Akslen, Lars A.
    Schlomm, Thorsten
    Kalland, Karl-Henning
    APMIS, 2009, 117 (08) : 575 - 582
  • [50] Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes
    Hendriks, Rianne J.
    Dijkstra, Siebren
    Jannink, Sander A.
    Steffens, Martijn G.
    van Oort, Inge M.
    Mulders, Peter F. A.
    Schalken, Jack A.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (03) : 483 - 492
12345